Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7394 p373
1 April 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Medicines management is failing older people

Medicines management in the health service is failing older people, according to a report published last week.

Few patients over the age of 75 years who regularly take more than four medicines are having their medicines reviewed every six months — missing one of the key targets set down in the National Service Framework for Older People when it was published five years ago, the report declares.

Some NHS trusts are failing to provide ward-based dispensing of drugs when older people are discharged from hospital and there is little evidence of community pharmacists helping older people manage their own medicines, it says.

The report, “Living well in later life”, was an assessment by the Healthcare Commission, the Audit Commission and the Commission for Social Care Inspection on progress made in the care of the elderly following publication of the NSF in March 2001.

The report was based on the inspections of services for older people provided by local authorities and the NHS in 10 districts in England and concluded that medicines management for this patient group needs to be addressed. It states: “None of the communities that were inspected was fully meeting the standards set out in the NSF for the management of medicines.”

Alison Blenkinsopp, professor of the practice of pharmacy at the department of medicines management at Keele University, was author of the medicines management guide for the NSF for Older People.

She said that although six monthly reviews of over 75s taking more than four medicines were not common practice, the new report was more optimistic about other medicines reviews of older people.

She said: “What I thought was quite positive from the report was that most GPs are reviewing [older] people’s medicines annually and that trusts are working with community pharmacists to carry out the reviews.”

Professor Blenkinsopp also suggested that medicines use reviews being carried out by pharmacists under the new pharmacy contract were not included in the report. The report instead relied on data from GP practices, which may have unfairly distorted the true picture of the number of reviews taking place. She said: “I think there may be an issue around how medicines use reviews that pharmacists are doing under the new contract are being recorded.”

Barbara Parsons, head of pharmacy practice at the Pharmaceutical Services Negotiating Committee, said: “The community pharmacy contract has re-engineered services to include medicines use review and prescription intervention which assists patients, including the elderly, to manage their medicines better.” She added that the PSNC has worked with other pharmacy organisations to produce a guide to the NSF for Older People, which includes evidence of good pharmacy practice.

The “Living well in later life” report is the latest to level criticism at the standards of medicines management for older people.

In February, a report by the Commission for Social Care Inspection painted a grim and chaotic picture of the standards of medicines support being offered in care homes in England (PJ, 11 February, p155 and 18 February, p198 PDF (80K)).

Back to Top


©The Pharmaceutical Journal